Nedaplatin: a new platinum for squamous lung cancer?

Lancet Oncol. 2015 Dec;16(16):1573-4. doi: 10.1016/S1470-2045(15)00400-3. Epub 2015 Oct 28.

Authors

Yin Wu¹, James Spicer²

Affiliations

¹ Department of Immunobiology, King's College London, Guy's Hospital, London SE1 9RT, UK.
² Division of Cancer Studies, King's College London, Guy's Hospital, London SE1 9RT, UK. Electronic address: james.spicer@kcl.ac.uk.

PMID: 26522336
DOI: 10.1016/S1470-2045(15)00400-3

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Squamous Cell / drug therapy*
Cisplatin / therapeutic use*
Docetaxel
Female
Humans
Lung Neoplasms / drug therapy*
Male
Neoplasm Recurrence, Local*
Organoplatinum Compounds / therapeutic use*
Taxoids / therapeutic use*

Substances

Organoplatinum Compounds
Taxoids
Docetaxel
nedaplatin
Cisplatin